|Mr. Sylvain Chretien||Pres & Director||N/A||N/A||1964|
|Mr. Roland Boivin||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Richard Labelle||VP of Sales & Marketing||N/A||N/A||N/A|
|Mr. Benoît Hébert||VP of Bus. Devel. & Licensing||N/A||N/A||1968|
|Mr. Normand Chartrand||Consultant||N/A||N/A||1959|
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was incorporated in 2003 and is headquartered in Verdun, Canada.
Medexus Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.